Bone News and Research

RSS

M. D. Anderson Cancer Center to investigate CTCE-9908 chemokine CXCR4 antagonist

Chemokine Therapeutics has announced that it has entered into an agreement with The University of Texas M. D. Anderson Cancer Center of Houston, Texas to study the Company's lead anti-cancer compound, CTCE-9908, a chemokine CXCR4 antagonist.

21 Feb 2006

Gum destruction can start in diabetic children as young as six years old

A new study from Columbia University Medical Center has shown that the destruction of the gums can start in diabetic children as young as six years old. While the link between diabetes and periodontal disease was previously established, it was believed that the regression of gums began much later and increased with age.

21 Feb 2006

New device to boost supply and quality of blood platelets

Cancer and open-heart surgery patients, disaster victims, organ or bone marrow transplant recipients, and others who require life-saving blood platelet transfusions will benefit from equipment invented by a researcher at the University of British Columbia's Centre for Blood Research (CBR).

21 Feb 2006

$Calcium and Vitamin D helps reduce risk of hip fractures in older women$

Calcium and Vitamin D helps reduce risk of hip fractures in older women

Taking calcium and Vitamin D slightly decreased the risk of hip fractures in older women, but not the risk for other types of fractures or for colorectal cancer, according to the latest findings from the federally funded Women's Health Initiative. Additionally, the supplements slightly increased the incidence of kidney stones.

21 Feb 2006

Calcium plus vitamin-D supplementation does an older body good

The older the woman, the more likely it is that consistent use of calcium and vitamin-D supplements will play a role in reducing her risk for osteoporosis, according to the results of a large national clinical trial conducted as part of the Women's Health Initiative (WHI).

20 Feb 2006

New guide helps doctors determine normal height loss

As we age we can expect to shrink an average of three to four centimeters. Such loss is normal due to shrinkage of the disks within the spine.

19 Feb 2006

Protein levels predict bone marrow transplant survival

Researchers say that protein levels can predict which bone marrow transplant patients are likely develop a deadly complication a week after the procedure and well before any symptoms occur.

19 Feb 2006

Farnesyltransferase inhibitor may improve progeria

UCLA researchers found that an experimental cancer drug improves the signs of progeria in a mouse model. Progeria is a rare genetic disease causing accelerated aging and cardiovascular disease in children. The new UCLA findings help to define a new strategy for treating children with progeria.

17 Feb 2006

Major Alzheimer's discovery

A team from the Faculty of Medicine at Universiti Laval and the research centre at CHUQ (Centre hospitalier universitaire de Quibec) has discovered a natural defence mechanism that the body deploys to combat nerve cell degeneration observed in persons with Alzheimer's disease (AD).

17 Feb 2006

Protein level predicts who will develop graft vs. host disease after marrow transplant

Researchers could determine one week after a bone marrow transplant which patients were likely to develop a serious and deadly complication, making them candidates for preventive treatment before any symptoms occur.

17 Feb 2006

New way to culture adult stem cells from bone marrow

In a significant advance for regenerative medicine, researchers at Rice University have discovered a new way to culture adult stem cells from bone marrow such that the cells themselves produce a growth matrix that is rich in important biochemical growth factors.

16 Feb 2006

Calcium and Vitamin D supplememts of limited benefit to older women

According to researchers at Stanford University Medical Center, older women who regularly take calcium and Vitamin D marginally decrease their risk of hip fractures.

16 Feb 2006

Stem cell injections may help those with severe peripheral artery disease

Indiana University School of Medicine scientists have begun a unique clinical trial using stem cell injections as a treatment that could offer hope to tens of thousands of people who face sores, ulcers and even amputations due to severe peripheral artery disease.

14 Feb 2006

Genzyme launches test to monitor Gleevec resistance

Genzyme Corporation has announced the availability of an important new test to monitor drug resistance in chronic myeloid leukemia (CML) patients who are treated with Gleevec (imatinib mesylate).

13 Feb 2006

Lupus responds to stem cell transplant therapy

Transplanting patients with blood stem cells that originate from their own bone marrow can induce the remission of life-threatening, treatment-resistant lupus, according to a study that took place at Northwestern Memorial Hospital in Chicago.

13 Feb 2006

Simple diagnostic imaging procedure changes treatment for lower back pain

A simple diagnostic imaging procedure can help identify patients with lower back pain who would benefit from spinal injections and spare those who would not, according to a study appearing in the February issue of Radiology.

13 Feb 2006

Older women who simply reduce the amount of total fat in their diet won't generally lower cancer risk

Older women who simply reduce the amount of total fat in their diet won't generally lower their risk of breast or colorectal cancer or heart disease, according to the latest findings from the federally funded Women's Health Initiative.

9 Feb 2006

FDA grants fast track status for ViroPharma's Maribavir

ViroPharma Incorporated has announced that the U.S. Food and Drug Administration (FDA) has granted fast track designation for maribavir, an oral antiviral drug candidate for the prevention of cytomegalovirus (CMV) infection in allogeneic bone marrow (stem cell) and solid organ transplant patients.

7 Feb 2006

Oncolytics Biotech granted new patent

Oncolytics Biotech Inc. has been granted U.S. Patent 6,994,858 entitled "Reovirus Clearance of Ras-Mediated Neoplastic Cells from Mixed Cellular Compositions."

7 Feb 2006

Mad cow proteins also maintain stem cells

What do mad cow disease and stem cell research have in common? Whitehead Institute scientists have found that the same protein that causes neurodegenerative conditions such as bovine spongiform encephalopathy (mad cow disease) is also important for helping certain adult stem cells maintain themselves.

7 Feb 2006